Income Statement - Entrada Therapeutics, Inc. (TRDA)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 25.42 | 210.78 | 129.01 | 25.26 | 0.00 | 0.00 | 0.00 |
| Cost of revenue | 4.10 | 3.77 | 99.88 | 1.90 | 1.12 | 0.33 | 0.10 |
| Gross profit | 21.33 | 210.78 | 129.01 | -1.90 | -1.12 | -0.33 | -0.10 |
| Total operating expenses | 177.32 | 163.77 | 132.18 | 97.25 | 51.13 | 26.34 | 11.82 |
| Operating income | -156.00 | 47.01 | -3.16 | -97.25 | -51.13 | -26.67 | -11.82 |
| Non-operating income (net) | 13.17 | 19.47 | 15.22 | 2.63 | -0.03 | 0.14 | 6.72 |
| Income before tax | -142.83 | 66.49 | 12.06 | -94.62 | -51.16 | -26.52 | -5.10 |
| Income tax expense | 0.92 | 0.86 | 18.74 | -7.16 | -1.09 | -0.14 | -0.45 |
| Net income | -143.75 | 65.63 | -6.69 | -87.46 | -50.07 | -26.52 | -4.65 |
Show Quarterly Income Statement
Income Statement - Entrada Therapeutics, Inc. (TRDA)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.88 | 1.30 | 1.61 | 1.95 | 20.56 | 37.40 | 19.57 | 94.69 | 59.12 | 41.85 | 43.74 | 18.17 | 25.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Cost of revenue | 0.81 | 0.89 | 38.36 | 1.10 | 0.99 | 0.90 | 0.90 | 0.93 | 0.74 | 22.19 | 26.30 | 23.10 | 0.53 | 0.50 | 0.50 | ||||||||||
| Gross profit | 0.07 | 0.41 | -36.75 | 1.95 | 20.56 | 37.40 | 19.57 | 94.69 | 59.12 | 41.85 | 21.54 | -8.13 | 2.16 | -0.53 | -0.50 | -0.50 | |||||||||
| Total operating expenses | 42.37 | 42.62 | 10.30 | 48.80 | 42.35 | 43.27 | 41.23 | 41.27 | 38.01 | 36.94 | 7.53 | 8.17 | 7.94 | 25.58 | 25.94 | 23.58 | 22.15 | 18.46 | 14.36 | 9.91 | 8.39 | 8.65 | 6.97 | 5.52 | 5.52 |
| Operating income | -42.30 | -42.21 | -47.05 | -46.85 | -21.79 | -5.87 | -21.66 | 53.42 | 21.11 | 4.91 | 14.01 | -16.30 | -5.78 | -25.58 | -25.94 | -23.58 | -22.15 | -18.46 | -14.36 | -9.91 | -8.39 | -8.65 | -6.97 | -5.52 | -5.52 |
| Non-operating income (net) | 2.62 | 3.14 | 3.57 | 3.92 | 4.44 | 5.13 | 5.77 | 4.37 | 4.21 | 4.29 | 38.85 | 4.22 | 2.66 | 0.95 | 0.80 | 0.40 | 0.48 | 0.01 | -0.07 | 0.01 | 0.01 | -0.02 | -0.02 | 0.09 | 0.09 |
| Income before tax | -39.68 | -39.07 | -43.48 | -42.93 | -17.35 | -0.74 | -15.89 | 57.79 | 25.33 | 9.20 | 52.86 | -12.08 | -3.12 | -24.63 | -25.14 | -23.18 | -21.67 | -18.45 | -14.43 | -9.90 | -8.38 | -8.67 | -6.99 | -5.43 | -5.43 |
| Income tax expense | 0.04 | 0.09 | 0.65 | 0.18 | -1.87 | -1.86 | 2.76 | 1.83 | 18.74 | 17.40 | 13.85 | 3.55 | -2.43 | -1.60 | -0.81 | -0.96 | -0.01 | ||||||||
| Net income | -39.72 | -39.16 | -44.13 | -43.10 | -17.35 | 1.13 | -14.03 | 55.03 | 23.50 | -9.54 | 35.46 | -25.93 | -6.67 | -24.63 | -25.14 | -23.18 | -21.67 | -18.45 | -14.43 | -9.90 | -8.38 | -8.67 | -6.99 | -5.43 | -5.43 |